DK1583538T3 - Anvendelse af 3-methozy-pregnenolon til fremstilling af et lægemiddel til behandling af neurodegenerative sygdomme - Google Patents

Anvendelse af 3-methozy-pregnenolon til fremstilling af et lægemiddel til behandling af neurodegenerative sygdomme

Info

Publication number
DK1583538T3
DK1583538T3 DK04702722T DK04702722T DK1583538T3 DK 1583538 T3 DK1583538 T3 DK 1583538T3 DK 04702722 T DK04702722 T DK 04702722T DK 04702722 T DK04702722 T DK 04702722T DK 1583538 T3 DK1583538 T3 DK 1583538T3
Authority
DK
Denmark
Prior art keywords
alpha
pregnenolone
medicament
methozy
manufacture
Prior art date
Application number
DK04702722T
Other languages
Danish (da)
English (en)
Inventor
Etienne-Emile Baulieu
Esther Fellous
Paul Robel
Original Assignee
Mapreg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mapreg filed Critical Mapreg
Application granted granted Critical
Publication of DK1583538T3 publication Critical patent/DK1583538T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Physiology (AREA)
  • Otolaryngology (AREA)
  • Nutrition Science (AREA)
  • Dermatology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
DK04702722T 2003-01-17 2004-01-16 Anvendelse af 3-methozy-pregnenolon til fremstilling af et lægemiddel til behandling af neurodegenerative sygdomme DK1583538T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0300507A FR2850023B1 (fr) 2003-01-17 2003-01-17 Medicaments pour le systeme nerveux
PCT/FR2004/000086 WO2004067010A1 (fr) 2003-01-17 2004-01-16 Utilisation de la 3-methoxy-pregnenolone pour la preparation d’un medicament destine a traiter les maladies neurodegeneratives

Publications (1)

Publication Number Publication Date
DK1583538T3 true DK1583538T3 (da) 2008-12-01

Family

ID=32605831

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04702722T DK1583538T3 (da) 2003-01-17 2004-01-16 Anvendelse af 3-methozy-pregnenolon til fremstilling af et lægemiddel til behandling af neurodegenerative sygdomme

Country Status (9)

Country Link
US (3) US8034798B2 (de)
EP (1) EP1583538B1 (de)
AT (1) ATE402710T1 (de)
DE (1) DE602004015406D1 (de)
DK (1) DK1583538T3 (de)
ES (1) ES2311790T3 (de)
FR (1) FR2850023B1 (de)
PT (1) PT1583538E (de)
WO (1) WO2004067010A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2850023B1 (fr) * 2003-01-17 2007-04-06 Mapreg Medicaments pour le systeme nerveux
WO2008109719A2 (en) * 2007-03-07 2008-09-12 Janssen Pharmaceutica N.V. Steroids derivatives as selective progesterone receptor modulators
CN103764151B (zh) * 2011-05-20 2017-05-17 国家医疗保健研究所 Cb1受体拮抗剂
ES2951664T3 (es) * 2011-09-08 2023-10-24 Sage Therapeutics Inc Esteroides neuroactivos, composiciones y usos de los mismos
US10259839B2 (en) * 2012-11-28 2019-04-16 Inserm (Institut National De La Sante Et De La Recherche Medicale) 3-(4′-substituted)-benzyl-ether derivatives of pregnenolone
EP3932932A1 (de) 2013-03-13 2022-01-05 Sage Therapeutics, Inc. Neuroaktive steroide und verfahren zur verwendung davon
EP4306114A1 (de) 2014-06-18 2024-01-17 Sage Therapeutics, Inc. Oxysterole und verfahren zu ihrer verwendung
MA42409A (fr) 2015-07-06 2018-05-16 Sage Therapeutics Inc Oxystérols et leurs procédés d'utilisation
RU2021100620A (ru) 2015-07-06 2021-01-29 Сейдж Терапьютикс, Инк. Оксистеролы и способы их применения
MY197698A (en) 2015-07-06 2023-07-06 Sage Therapeutics Inc Oxysterols and methods of use thereof
EP3165225A1 (de) 2015-11-06 2017-05-10 Mapreg Nicht biologisch umsetzbare c3-substitutierte pregnenolonderivate zur behandlung von drogenmissbrauch
US9943528B2 (en) 2016-03-01 2018-04-17 Mapreg Non-bioconvertible C3-substituted pregnenolone derivatives for use in the treatment of treatment-resistant depression
WO2017149339A1 (en) 2016-03-01 2017-09-08 Mapreg Non-bioconvertible c3-substituted pregnenolone derivatives for use in the treatment of treatment-resistant depression
LT3436022T (lt) 2016-04-01 2022-06-27 Sage Therapeutics, Inc. Oksisteroliai ir jų panaudojimo būdai
WO2017193046A1 (en) 2016-05-06 2017-11-09 Sage Therapeutics, Inc. Oxysterols and methods of use thereof
ES2884071T3 (es) 2016-07-07 2021-12-10 Sage Therapeutics Inc 24-hidroxiesteroles sustituidos en 11 para el tratamiento de afecciones relacionadas con NMDA
CN110023323A (zh) 2016-09-30 2019-07-16 萨奇治疗股份有限公司 C7取代的氧固醇及其作为nmda调节剂的方法
CA3041088C (en) 2016-10-18 2024-05-21 Sage Therapeutics, Inc. Oxysterols and methods of use thereof
MA46565A (fr) 2016-10-18 2019-08-28 Sage Therapeutics Inc Oxystérols et leurs procédés d'utilisation

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5563131A (en) * 1994-08-04 1996-10-08 Pherin Corporation Pregnane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
JP4313435B2 (ja) * 1995-07-24 2009-08-12 トラスティーズ オブ ボストン ユニバーシティー プレグネノロンサルフェート誘導体によるnmdaレセプター活性の抑制
US6245757B1 (en) * 1997-10-03 2001-06-12 Research Corporation Technologies, Inc. Use of progestins to treat ischemic event
FR2806303B1 (fr) * 2000-03-17 2002-09-27 Inst Nat Sante Rech Med Composes capables de se lier a des proteines constituantes ou associees aux elements du cytosquelette et leurs applications pour la fabrication de medicaments
US20020072509A1 (en) * 2000-10-11 2002-06-13 Stein Donald Gerald Methods for the treatment of a traumatic central nervous system injury
WO2002036128A1 (en) * 2000-11-06 2002-05-10 Trustees Of Boston University Neuroactive steroid derivatives and methods of use
EP1310258A1 (de) * 2001-11-08 2003-05-14 Etienne-Emile Baulieu Steroid-Enantiomere zur Erhöhung des Erinnerungsvermögens und der kognitiven Funktion
FR2850023B1 (fr) * 2003-01-17 2007-04-06 Mapreg Medicaments pour le systeme nerveux
US9339508B2 (en) * 2003-01-17 2016-05-17 Mapreg Use of 3-methoxy-pregnenolone for the preparation of a drug for treating a traumatic brain injury

Also Published As

Publication number Publication date
ATE402710T1 (de) 2008-08-15
US20060199790A1 (en) 2006-09-07
EP1583538A1 (de) 2005-10-12
US8334278B2 (en) 2012-12-18
DE602004015406D1 (de) 2008-09-11
WO2004067010A1 (fr) 2004-08-12
FR2850023B1 (fr) 2007-04-06
US8034798B2 (en) 2011-10-11
ES2311790T3 (es) 2009-02-16
PT1583538E (pt) 2008-10-30
US20090143347A1 (en) 2009-06-04
US20160166586A1 (en) 2016-06-16
FR2850023A1 (fr) 2004-07-23
EP1583538B1 (de) 2008-07-30
US10561671B2 (en) 2020-02-18

Similar Documents

Publication Publication Date Title
DK1583538T3 (da) Anvendelse af 3-methozy-pregnenolon til fremstilling af et lægemiddel til behandling af neurodegenerative sygdomme
UA85708C2 (ru) Лекарственные комбинации, содержащие бензоксазины, для лечения заболеваний дыхательных путей
GEP20053595B (en) Cyclopentanoindoles, Compositions Containing Such Compounds and Methods of Treatment
BRPI0720551A2 (pt) composto ou um sal farmaceuticamente aceitável do mesmo, e, uso do mesmo, método para o tratamento de câncer, processos para a preparação de uma composição farmacêutica e de um composto ou de um sal farmaceuticamente aceitável do mesmo
NO20092723L (no) Indazolylester og amidderivater for behandling av gluccocorticoid reseptormedierte sykdommer
ATE339406T1 (de) Chinazoline verbindungen als heilmittel
NO20070576L (no) Nye hydantionderivater for behandling av obstruktive luftveissykdommer.
PT1326613E (pt) Utilizacao de derivados de imidazo[1,2-a]piridin-,imidazo[1,2-a]pirimidin- e imidazo[1,2-a]pirazin-3-il-amina substituidos para a fabricacao de medicamentos para inibicao de nos
HK1062677A1 (en) 17Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
WO2005075425A3 (en) Substituted bisarylurea derivatives as kinase inhibitors
IS8230A (is) Setið 2-amínótetralín til notkunar við meðferð á þunglyndi
ATE442142T1 (de) Fredericamycin-derivate als arzneimittel zur tumorbehandlung
DE60315492D1 (de) Medizinisch verwendbare arylethanolamin verbindungen
NO20091938L (no) 7,8-dihydro-1,6-naftyridin-5(6H)-oner og relaterte bicykliske forbindelser som inhibitorer av dipeptidyl-peptidaser IV og metoder
BR0315580A (pt) Derivados de metileno uréia
SG148177A1 (en) Novel cis-imidazolines
CY1109045T1 (el) Ρετινοειδη για τη θεραπεια του εμφυσηματος
WO2005037798A3 (en) Amide or thiomide derivatives and their use in the treatment of pain
UA90504C2 (ru) Лекарственное средство для лечения заболеваний дыхательных путей
MXPA05010020A (es) Derivados de oxamida.
MXPA05005790A (es) Aminoalcoxiindoles como ligandos del receptor 5-ht6 para el tratamiento de enfermedades del sistema nervioso central.
DE60215313D1 (de) Indolderivate und deren verwendung als gnrh antagonisten
DK1511496T3 (da) Fremgangsmåde til behandling eller forebyggelse af immunmedierede sygdomme og farmaceutisk præparat til anvendelse heri
EA200870223A1 (ru) Производные бензоизоиндола для лечения боли
AU2001246999A1 (en) New neurokinin antagonists for use as medicaments